Target intelligence / Profile preview

Cell-surface anionic membranes and heparan sulfate proteoglycans (HSPG)

Target
HSPG
Molecular classification
Proteoglycan, Glycoprotein, Lipid membrane component, Receptor
01

Overview

Cell-surface anionic membranes and heparan sulfate proteoglycans (HSPGs) constitute a negatively charged interface on the plasma membrane that plays a pivotal role in cellular communication and pathogen entry. HSPGs, including the syndecan and glypican families, consist of core proteins decorated with heparan sulfate glycosaminoglycan chains that bind a diverse array of ligands such as growth factors, cytokines, and extracellular matrix components (Sarrazin et al., 2011, Cold Spring Harb Perspect Biol). The anionic charge of these membranes, contributed by both the sulfate groups on HSPGs and acidic phospholipids, facilitates the initial electrostatic recruitment of cationic molecules, including cell-penetrating peptides and viral attachment proteins (Magzoub & Gräslund, 2004, Q Rev Biophys). Many viruses, such as SARS-CoV-2, HIV-1, and Herpes Simplex Virus, utilize HSPGs as primary attachment receptors to concentrate viral particles on the cell surface before engaging specific entry receptors (Cagno et al., 2019, Rev Med Virol). In therapeutic contexts, these structures are targeted by polyanionic mimetics or cationic peptides to block viral infection, inhibit tumor angiogenesis, or facilitate the delivery of macromolecular drugs (Wadajkar et al., 2013, J Control Release).

Other names
Cell-surface glycansHeparan sulfateSyndecansGlypicansAnionic phospholipidsCell-surface glycosaminoglycans
02

Mechanism of action

Competitive inhibition of ligand binding to heparan sulfate chains and electrostatic neutralization of anionic membrane surfaces to prevent viral or molecular entry.

03

Biological functions

Cell adhesionSignal transductionViral attachmentEndocytosisGrowth factor sequestration
04

Disease associations

InfectionCancerInflammationCardiovascular disease
05

Safety considerations

Non-specific bindingInterference with physiological growth factor signalingPotential for systemic toxicityAnticoagulant effects
06

Interacting drugs

Heparin

6 more in the full profile.

07

Biomarkers

Syndecan-1 (CD138) expressionHeparanase levelsGlypican-3 expression

Beyond the preview

Go deeper on Cell-surface anionic membranes and heparan sulfate proteoglycans (HSPG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-surface anionic membranes and heparan sulfate proteoglycans (HSPG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call